Please use this identifier to cite or link to this item:
https://scholars.lib.ntu.edu.tw/handle/123456789/621332
Title:
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial